期刊文献+

回肠间置术对糖尿病大鼠糖脂代谢的影响

Effects of ileal interposition on glucose and lipid metabolism in Goto-kakizaki rats
下载PDF
导出
摘要 目的 :观察回肠间置术(IT)对非肥胖型糖尿病GK大鼠血糖及血脂的影响。方法:选取12周龄的雄性GK大鼠30只,随机分为IT组10只、假手术饮食控制组(C组)10只,及假手术空白对照组(B组)10只。观察三组实验动物手术前后进食量、体质量、血糖情况。术前、术后第4、第8周进行糖耐量试验。术前、术后8周取血,检测血清总胆固醇、甘油三酯、高密度脂蛋白。结果:IT组的术后空腹血糖明显低于术前以及另外两组。IT组术后第4、第8周糖耐量曲线下面积较术前明显缩小,而其他两组基本无变化。和B组相比,IT组术后血脂得到明显改善,C组术后血脂变化差异无统计学意义(P>0.05)。结论:IT可明显改善非肥胖型糖尿病GK大鼠糖脂类代谢。 Objective: To observe the effects of ileal interposition on blood glucose and blood lipid in the Goto-kakizaki rats. Methods: Thirty 12-week-old GK rats were randomly assigned to three groups:ileal trans- position group (IT, n=10), control group which diet was controlled as IT group after sham operation (C, n=10); blank group which were given normal diet after operation (B, n=10). Before and after surgery, the changes of weight, food intake, fasting glucose were observed. Glucose tolerance tests were checked before operation and at 4, 8 weeks after operation. Serum total cholesterol, triglycerides, high-density lipoprotein cholesterol were checked, before and 8 weeks after operation. Results: After operation, the fasting glucose and AUC of group IT was significantly lower compared with other two groups. In addition, the blood lipid of IT-operated GK rats was obviously improved. Conclusion: Ileal interposition is effective in improving the metabolism of glucose and lipid in GK rats.
出处 《温州医学院学报》 CAS 2013年第4期215-218,共4页 Journal of Wenzhou Medical College
基金 教育部高等学校博士点专项科研基金资助项目(20103321120001) 浙江省自然科学基金资助项目(Y2110335) 浙江省卫生厅医药卫生一般科研计划项目(2011KYA111) 温州市科技局科研基金资助项目(H20100058) 浙江省教育厅科研基金资助项目(Y201120785)
关键词 回肠间置术 糖尿病 2型 GK大鼠 血脂 ileal interposition diabetes mellitus, type 2 GK rats blood lipid
  • 相关文献

参考文献9

  • 1Koopmans HS, Sclafani A. Control of body weight by lower gut signals[J]. Int J Obes, 1981, 5(5):491-495.
  • 2Wang TT, Hu SY, Gao HD, et al. Ileal transposition con- trols diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type I/ diabetes by increasing GLP-1 [J]. Ann Surg, 2008, 247(6): 968-975.
  • 3Mason EE. The mechanism of surgical treatment of type 2 diabetes[J]. Obes Surg, 2005, 15(4):459-461.
  • 4杨红旺,刘洋,袁勃,孟雁.GLP-1的生理作用与临床[J].中国糖尿病杂志,2009,17(1):78-80. 被引量:26
  • 5Strader AD, Clausen TR, Goodin SZ, et al. Ileal interposition improves glucose tolerance in low dose streptozotocin- treated diabetic and euglycemic rats[J]. Obes Surg, 2009, 19 (1):96-104.
  • 6Patriti A, Aisa MC, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L- cell number[J]. Surgery, 2007, 142(1):74-85.
  • 7Sancho V, Trigo MV, Martin-Duce A, et al. Effect of GLP- 1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects[J]. Int J Mol Med, 2006, 17(6): 1133-1137.
  • 8Gagner M. Laparoscopic sleeve gastrectomy with ileal in- terposition (SGIT):a modified duodenal switch for resolu- tion of type 2 diabetes mellitus in lesser obese patients (BMI <35)[J]. World J Surg, 2011, 35(1): 109-110.
  • 9Boza C, Munoz R, Yung E, et al. Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proxi- mal intestine[J]. J Gastrointest Surg, 2011, 15(6):928-934.

二级参考文献13

  • 1Ranganath LR. The entero-insular axis: implications for human metabolism. Clin Chem Lab Med, 2008, 46:43-56.
  • 2Drucker DJ. Glucagon like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol, 2003, 17: 161-171.
  • 3MacDonald PE, Salapatek AM, Wheeler MB. Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K (+) currents in beta cells: a possible glucose-dependent insulinotropic mechanism. Diabetes, 2002, 51 ( Suppl 3 ): S443-S447.
  • 4Dyachok O, Isakov Y, Saqetorp J, et al. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells. Nature, 2006, 439: 349-352.
  • 5Zhou J, Egan JM. SNAP-25 is phosphorytated by glucose and GLP-1 in RIN 1046-38 cells. Bioehem Biophys Res Commun, 1997, 238: 297-300.
  • 6Klinger S, Poussin C, Debril MB, et al. Increasing GLP-1-induced beta cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes, 2008, 57: 584-593.
  • 7Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes, 1999, 48: 2270-2276.
  • 8Friedrichsen BN, Neubauer N, Lee YC, et al. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinul, 2006, 188: 481-492.
  • 9Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology, 2003, 144 5149-5158.
  • 10Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care, 2005, 28: 1083-1091.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部